C
ISSUER//CIK 0001412067
Cascadian Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K56.1 KBOncothyreon Inc.Jan 5, 4:46 PM ET·0001193125-12-003648
- 49.3 KBOncothyreon Inc.Jan 3, 3:18 PM ET·0001179110-12-000036
- 8-K61.5 KBOncothyreon Inc.Sep 12, 8:05 AM ET·0001193125-11-245055
- 48.3 KBOncothyreon Inc.Jun 13, 5:44 PM ET·0001209191-11-034352
- 8-K18.2 KBOncothyreon Inc.Jun 13, 1:21 PM ET·0000950123-11-058571
- 8-K17.1 KBOncothyreon Inc.Jan 4, 5:01 PM ET·0000950123-11-000326
- S-1513.2 KBOncothyreon Inc.Oct 4, 5:14 PM ET·0000950123-10-091166
- 8-K36.4 KBOncothyreon Inc.Aug 3, 4:04 PM ET·0000950123-09-028894
- 47.7 KBOncothyreon Inc.Jan 18, 5:42 PM ET·0001179110-08-001414
- 8-K47.6 KBOncothyreon Inc.Jan 2, 4:16 PM ET·0001279569-08-000005
Insiders
5Tickers
No tickers on record
Addresses
business
3101 WESTERN AVE. SUITE 600
SEATTLE, WA, 98121
mailing
3101 WESTERN AVE. SUITE 600
SEATTLE, WA, 98121
Former Names
- Oncothyreon Inc.2016-06-09
- Biomira CORP2007-09-27